Stratipath Medical
Stratipath is an AI company spun out from Karolinska Institutet in Stockholm, Sweden, focused on revolutionizing cancer treatment decisions and improving patient outcomes through AI-based precision diagnostics. Their flagship product, Stratipath Breast, is a CE-IVD marked AI solution for prognostic risk profiling of invasive early-stage breast cancer, providing a faster, cheaper alternative to gene expression testing. The platform analyzes routine histopathology images to identify patients' risk of disease progression, enabling earlier and more precise treatment decisions. Stratipath's SaaS platform integrates with digital pathology workflows and is validated in large-scale independent studies, currently in clinical use across healthcare providers in the EU and UK. The company leverages unique multi-source population-representative datasets and deep learning technologies to develop scalable AI diagnostic solutions for healthcare, clinical trials, and drug development, aiming to expand access to precision medicine globally.
Stratipath Medical
Stratipath is an AI company spun out from Karolinska Institutet in Stockholm, Sweden, focused on revolutionizing cancer treatment decisions and improving patient outcomes through AI-based precision diagnostics. Their flagship product, Stratipath Breast, is a CE-IVD marked AI solution for prognostic risk profiling of invasive early-stage breast cancer, providing a faster, cheaper alternative to gene expression testing. The platform analyzes routine histopathology images to identify patients' risk of disease progression, enabling earlier and more precise treatment decisions. Stratipath's SaaS platform integrates with digital pathology workflows and is validated in large-scale independent studies, currently in clinical use across healthcare providers in the EU and UK. The company leverages unique multi-source population-representative datasets and deep learning technologies to develop scalable AI diagnostic solutions for healthcare, clinical trials, and drug development, aiming to expand access to precision medicine globally.